Skip to main content
Sign In
 

2018 Preliminary Program


 Keynote Address: “Bringing Light to COPD Pathogenesis and Resilience”

Rubin M.Tuder, M.D.

Aurora, Colorado ​

1

 ​“Targeting COPD Phenotypes, Endotypes and Biomarkers”

Prescott G. Woodruff, M.D. 

San Francisco, California

2

 “Applying Functional Genomics to COPD”

Edwin K. Silverman, M.D., Ph.D.

Boston, Massachusetts​​

16

 “Early COPD: Improving Early Detection, Prevention and Treatment”

Meilan King Han, M.D.

Ann Arbor, Michigan​​

3

 "Role of Senescence in COPD Pathogenesis”

Mary Y. Armanios, M.D.

Baltimore, Maryland​​

4

 "Stem/Progenitor Cell Dysfunction in the Pathogenesis of COPD"

Jayaraj Rajagopal, M.D.

Boston, Massachusetts

5

 "Cell-Based Therapy for COPD: Rebuilding the Lung”

Daniel J. Weiss, M.D., Ph.D.

Burlington, Vermont

6

 Clinical Perspective: “Taming the Tiger: Burden, Consequences and Challenges of COPD Exacerbations”

Jadwiga A. Wedzicha, M.D.

London, United Kingdom​​

7

 “COPD Exacerbations and Immune Dysfunction”

Alison A. Humbles, Ph.D.

Cambridge, United Kingdom

8

 "Immune/Epithelial Interactions in the Pathogenesis of COPD Exacerbations”

Michael J. Holtzman, M.D.

St. Louis, Missouri ​​

9

 “Mitochondrial and Metabolic Dysfunction in the Development of COPD”

Augustine M.K. Choi, M.D.

New York, New York​​

10

 “Bioactive Lipids in the Pathogenesis of Airways Disease and Emphysema”

Irina Petrache, M.D. 

Denver, Colorado​
11

 "COPD and Lung Cancer: Common Pathogenesis”

A. McGarry Houghton, M.D.

Seattle, Washington ​​

12

 "COPD and Pulmonary Vascular Disease: Comorbidity in Search of a Treatment”

Norbert Weissmann, Ph.D.

Geissen, Germany​​

13

 NHLBI Perspective: "NHLBI Critical Challenges and Compelling Questions for COPD: Moving the Field Forward”

Thomas L. Croxton, Ph.D., M.D.

Bethesda, Maryland ​​

14

 Conference Summary

Stephen I. Rennard, M.D.

Omaha, Nebraska and Cambridge, United Kingdom​​

15